Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Exelixis and Pharmacia & Upjohn expand collaboration

Nov. 10, 1999

ASN presentation for VNA-932, a potent and selective, nonpeptide V2 agonist

Nov. 9, 1999

Helix BioPharma finalizes acquisition of PharmaDerm

Nov. 9, 1999

Idun identifies X-ray structure of caspase 8

Nov. 8, 1999

Abgenix and Pfizer add third antigen target to collaboration agreement

Nov. 5, 1999

HepaVec and CSIRO sign option agreement for ovine viral vector technology

Oct. 25, 1999

Mechanistically novel iNOS inhibitors identified during Pharmacopeia/Berlex joint project

Oct. 22, 1999

Inhale acquires novel particle formulation technology for lung delivery

Oct. 22, 1999

Technology acquisition broadens and accelerates ICAgen's R&D programs

Oct. 20, 1999

New drug discovery collaboration with Organon announced by Pharmacopeia

Oct. 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...